Scarica l'app Stockscreener
2.26
0.00%
0.00
Dopo l'orario di chiusura:
2.25
-0.010
-0.44%
Precedente Chiudi:
$2.26
Aprire:
$2.21
Volume 24 ore:
563.97K
Relative Volume:
0.98
Capitalizzazione di mercato:
$100.73M
Reddito:
$19.94M
Utile/perdita netta:
$-37.37M
Rapporto P/E:
-1.7795
EPS:
-1.27
Flusso di cassa netto:
$-33.38M
1 W Prestazione:
-16.91%
1M Prestazione:
+11.33%
6M Prestazione:
-62.77%
1 anno Prestazione:
-28.71%
Intervallo 1D:
$2.20
$2.3399
Intervallo di 1 settimana:
$2.20
$2.87
Portata 52W:
$1.66
$8.1939
Werewolf Therapeutics Inc Stock (HOWL) Company Profile
Nome
Werewolf Therapeutics Inc
Settore
Industria
Telefono
617-952-0555
Indirizzo
200 TALCOTT AVENUE, WATERTOWN
Werewolf Therapeutics Inc Stock (HOWL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-09-10 | Iniziato | BofA Securities | Buy |
| 2021-05-25 | Iniziato | Evercore ISI | Outperform |
| 2021-05-25 | Iniziato | H.C. Wainwright | Buy |
| 2021-05-25 | Iniziato | Jefferies | Buy |
| 2021-05-25 | Iniziato | SVB Leerink | Outperform |
Werewolf Therapeutics Inc Borsa (HOWL) Ultime notizie
Werewolf Therapeutics announces IL-10 Indukine development candidate for inflammatory bowel disease - BioWorld Online
Werewolf Therapeutics expands pipeline with new IBD candidate - Investing.com
Panbela to Host Third Quarter 2024 Earnings Conference Call on November 14, 2024 - The Manila Times
Werewolf Therapeutics Announces Promising New Development - GlobeNewswire
Werewolf Therapeutics Announces Promising New Development Candidate, WTX-921, a first-of-its-kind IL-10 INDUKINE™ Molecule for Inflammatory Diseases - StockTitan
WisdomTree Inc (NYSE: WT): Blank Check On Growth? - Stocks Register
Werewolf To Provide Clinical Update On WTX-330 - RTTNews
Werewolf Therapeutics Inc (NASDAQ: HOWL) Could Pass $12 In One Year Stock Forecast - Stocks Register
Social Security Just Released the 2025 COLA. Here's What It Means for Those Receiving Spousal Benefits. - Yahoo! Voices
Could Buying Apple Stock Today Set You Up for Life? - Yahoo! Voices
Is Summit Therapeutics Inc. (SMMT) the Best QQQ Stock to Buy According to Analysts? - Yahoo Finance
Lyft is working on a ‘service animal opt-in feature’ for passengers - Yahoo! Voices
Hammond packaging facility to get $35M upgrade - Yahoo! Voices
2 Game-Changing Artificial Intelligence (AI) Stocks to Buy Right Now (Hint: Not Nvidia) - Yahoo! Voices
Poland’s stunning success should be discomforting for Britain - Yahoo! Voices
Every UPS Investor Should Keep an Eye on This Number - Yahoo! Voices
Billionaire Philippe Laffont Just Increased His Position by 139% in This Data Center Opportunity (Hint: It's Not Nvidia) - Yahoo! Voices
We're Not Very Worried About Mineralys Therapeutics' (NASDAQ:MLYS) Cash Burn Rate - Yahoo Finance
ProQR Therapeutics (NASDAQ:PRQR) shareholder returns have been solid, earning 231% in 1 year - Yahoo Finance
Bank of America Predicts up to ~390% Surge for These 2 ‘Strong Buy’ Stocks - Yahoo Finance
Cut the state to get growing - Yahoo! Voices
‘It’s huge’: Striking Boeing workers near deal - Yahoo! Voices
National Association of Black Accountants’ St. Louis Chapter honors 50 years of community impact - Yahoo! Voices
Voya Financial Reports $341 Billion AUM Milestone - Yahoo Finance
Viking Therapeutics, Inc. (VKTX) Exceeds Market Returns: Some Facts to Consider - Yahoo Finance
mRNA licensing agreements surge 800% amid GSK lawsuits - Yahoo Finance
State Street Corp's Strategic Reduction in Viridian Therapeutics Inc - Yahoo Finance
State Street Corp's Strategic Reduction in Viking Therapeutics Holdings - Yahoo Finance
Nvidia to be the first company to hit $4T market cap: Lumida CEO - Yahoo Finance
LGT incorporates its Barcelona digital hub - Yahoo News
Amicus Therapeutics (FOLD) Stock Jumps 14.0%: Will It Continue to Soar? - Yahoo Finance
Millennium Management LLC's Strategic Reduction in Esperion Therapeutics Inc Holdings - Yahoo Finance
NantHealth (NASDAQ:NH) Coverage Initiated by Analysts at StockNews.com - Defense World
StockNews.com Downgrades Nomad Foods (NYSE:NOMD) to Hold - Defense World
Microsoft said it lost weeks of security logs for its customers' cloud products - Yahoo! Voices
TuHURA Biosciences Completes Merger Transaction with Kintara Therapeutics - Yahoo Finance
State Street Corp's Strategic Acquisition in Beam Therapeutics Inc - Yahoo Finance
Walgreens has more than 100 stores in Indiana. Company plans to shut down 1,200 nationwide - Yahoo News
Dogwood Therapeutics, Inc. Expected to Earn Q3 2024 Earnings of ($1.40) Per Share (NASDAQ:DWTX) - Defense World
Amicus Therapeutics Settles Patent Lawsuit Teva Pharmaceuticals Over Generic Version Of Its Rare Genetic Disorder Drug - Yahoo Finance
AQR Capital Management LLC Has $331,000 Stock Holdings in Scholar Rock Holding Co. (NASDAQ:SRRK) - Defense World
6,661 Shares in Fortune Brands Innovations, Inc. (NYSE:FBIN) Acquired by Sanctuary Advisors LLC - Defense World
After Series Of Trial Setbacks, Sage Therapeutics To Lay Off One-Third Workforce - Yahoo Finance
Outlook Therapeutics® Participates in a Virtual Investor CEO Connect Segment - Yahoo Finance
Power Co. of Canada (TSE:POW) Receives C$43.28 Average Target Price from Brokerages - Defense World
AQR Capital Management LLC Makes New Investment in Canadian Natural Resources Limited (NYSE:CNQ) - Defense World
Tevogen Investors Congratulate on Prestigious Recognition of Pioneering Biopharma Business Model, Breakthrough Innovations, Building Assets Estimated to Exceed $10 Billion - Yahoo Finance
Wells Fargo & Company Increases AptarGroup (NYSE:ATR) Price Target to $185.00 - Defense World
Q4 2025 Earnings Estimate for Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Issued By Zacks Research - Defense World
London Stock Exchange Group (LON:LSEG) Trading 0.6% Higher – Here’s What Happened - Defense World
Finward Bancorp (OTCMKTS:FNWD) Trading Down 1% – Time to Sell? - Defense World
Werewolf Therapeutics Inc Azioni (HOWL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.02%
0.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):